georgeclerk
- Although Pfizer (NYSE:PFE) reiterated 2025 financial guidance issued in December, the midpoints of the ranges for revenue and EPS are below consensus figures.
- The pharmaceutical giant is projecting revenue of $61B-$64B (midpoint $62.5B) this year. Consensus is $63B. EPS is estimated at $2.80-$3.00 (midpoint $2.90). Consensus is $2.93.